https://www.onclive.com/onclive-tv/dr-vokes-on-pembrolizumab-plus-chemotherapy-and-radiation-in-lung-cancer
Dr. Vokes on Pembrolizumab Plus Chemotherapy and Radiation in Lung Cancer

Everett Vokes, MD



Everett Vokes, MD, John E. Ultmann Professor of Medicine and Radiation Oncology, physician-in-chief, chair, Department of Medicine, University of Chicago Medicine, discusses pembrolizumab (Keytruda) plus chemotherapy and radiation therapy in patients with lung cancer.

According to Vokes, pembrolizumab, chemotherapy, and radiation is a relevant treatment option for patients with lung cancer. There was a trial investigating this for patients with nonsquamous non-small cell lung cancer (NSCLC), which accrued 500 patients. It showed no difference in progression-free survival and overall survival, states Vokes.
 
Printer Printing...